In vitro inhibition of helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by lactobacillus paraplantarum KNUC25 isolated from kimchi

Journal of Medicinal Food

Volumn 13, Issue 3, 2010, Pages 629-634

  Ki, Mi Ran ^a   Ghim, Sa Youl ^a   Hong, Il Hwa ^a   Park, Jin Kyu ^a   Hong, Kyung Sook ^a   Ji, Ae Ri ^a   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

Author keywords

adhesion; anti Helicobacter pylori; cagA; gastric cancer cell; probiotics

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL ENZYME; CAGA PROTEIN; GENOMIC DNA; LACTIC ACID; PROBIOTIC AGENT; SODIUM CHLORIDE; UREASE; VACUOLATING TOXIN;

ACIDITY; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CAGA GENE; CELL FREE SYSTEM; CELL STRAIN; CELL STRAIN AGS; CONTROLLED STUDY; DISK DIFFUSION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FERMENTED PRODUCT; GROWTH INHIBITION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; KIMCHI; KOREA; LACTOBACILLUS PLANTARUM; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH EPITHELIUM; VACA GENE;

ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; BRASSICA; CELL LINE; EPITHELIAL CELLS; FERMENTATION; HELICOBACTER PYLORI; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS; STOMACH;

HELICOBACTER PYLORI; LACTOBACILLUS PARAPLANTARUM; NEGIBACTERIA; POSIBACTERIA;

EID: 77953768369     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.1265     Document Type: Article

References (37)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;16:1311-1315.
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-69.
3. International Agency for Research on Cancer: Evaluation of carcinogenic risks to humans, schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240.
4. Blaser MJ, Perez-Perez GI, Kleanthous H, et al.: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-2115.
5. Evans DJ Jr, Evans DG, Takemura T, et al.: Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun 1995;63:2213-2220.
6. Ishiki K,Mizuno M, Take S, et al.: Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol 2004;2:474-479.
7. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
8. Naja F, Kreiger N, Sullivan T: Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007; 21:501-506.
9. Kang JM, Kim N, Lee DH, et al.: Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. Helicobacter 2007;12: 623-628.
10. Queiroz DM, Dani R, Silva LD, et al.: Factors associated with treatment failure of Helicobacter pylori infection in a developing country. J Clin Gastroenterol 2002;35:315-320.
11. Sheu BS, Cheng HC, Yang YJ, Yang HB, Wu JJ: The presence of dental disease can be a risk factor for recurrent Helicobacter pylori infection after eradication therapy: a 3-year follow-up. Endoscopy 2007;39:942-947.
12. McMahon BJ, Bruce MG, Hennessy TW, et al.: Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment Pharmacol Ther 2006;23: 1215-1223.
13. Kim MN, Kim N, Lee SH, et al.: The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008;13:261-268.
14. Franceschi F, Cazzato A, Nista EC, et al.: Role of probiotics in patients with Helicobacter pylori infection. Helicobacter 2007; 12(Suppl 2):59-63.
15. Food and Agriculture Organization of the United Nations and World Health Organization: Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria: Report of a Joint FAO=WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Amerian Córdoba Park Hotel, Córdoba, Argentina, 1-4 October 2001. www.who.int=foodsafety=publications=fs-management=en= probiotics.pdf (accessed 15 February 2010).
16. Rolf RD: The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000;130(2S Suppl):396S-402S.
17. Vandenbergh PA: Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993;12:221-238.
18. Canducci F, Armuzzi A, Cremonini F, et al.: A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14:1625-1629.
19. Sgouras D, Maragkoudakis P, Petraki K, et al.: In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004;70:518-526.
20. Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A: Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL=6 mice. Clin Diagn Lab Immunol 2005;12:1378-1386.
21. Lionetti E, Miniello VL, Castellaneta SP, et al.: Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006;24:1461-1468.
22. Ryan KA, Daly P, Li Y, Hooton C, OToole PW: Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother 2008;61:831-834.
23. Ahn DK, Han TW, Shin HY, Jin IN, Ghim SY: Diversity and antibacterial activity of lactic acid bacteria isolated from Kimchi. Korean J Microbiol Biotechnol 2003;31:191-196.
24. Han TW: Microbiological control for sanitary safety of commercial Kimchi [Masters Thesis]. Kyungpook National University, Daegu, Republic of Korea, 2005. www.kimchi.or.kr=eng=about=info=efficacy=11778543938.html (accessed June 25, 2009).
25. Cheigh HS, Park KY: Biochemical, microbiological, nutritional aspects of kimchi (Korean fermentaed vegetable products). Crit Rev Food Sci Nutr 1994;34:175-203.
26. Kim M, Lee SJ, Seul KJ, Park YM, Ghim SY: Characterization of antimicrobial substance produced by Lactobacillus paraplantarum KNUC25 isolated form Kimchi. Korean J Microbiol Biotechnol 2009;37:24-32.
27. Lee HM, Lee YH: Isolation of Lactobacillus plantarum from kimchi and its inhibitory activity on the adherence and growth of Helicobacter pylori. J Microbiol Biotechnol 2006;16:1513-1517.
28. Rokka S, Pihlanto A, Korhonen H, Joutsjoki V: In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett Appl Microbiol 2006;43: 508-513.
29. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-17777.
30. Lee A, ORourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-1397.
31. Ki MR, Hong IH, Park JK, et al.: Potent neutralization of vacuolating cytotoxin (VacA) of Helicobacter pylori by immunoglobulins against the soluble recombinant VacA. Anticancer Res 2009;29:2393-2402.
32. Ki MR, Lee HR, Goo MJ, et al.: Differential regulation of ERK1=2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008;294:G635-G647.
33. Lee KH, Park JY, Jeong SJ, et al.: Characterization of paraplantaricn C7, a novel bacteriocin produced by Lactobacillus paraplantarum C7 isolated from kimchi. J Microbiol Biotechnol 2007;17:287-296.
34. Crowe SE, Alvarez L, Dytoc M, et al.: Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995;108:65-74.
35. Kaji T, Ishihara S, Ashizawa A, et al.: Adherence of Helicobacter pylori to gastric epithelial cells and mucosal inflammation. J Lab Clin Med 2002;139:244-250.
36. Zhang ZW, Dorrell N, Wren BW, Farthingt MJ: Helicobacter pylori adherence to gastric epithelial cells: a role for non-adhesin virulence genes. J Med Microbiol 2002;51:495-502.
37. Ryan KA, OHara AM, van Pijkeren JP, Douillard FP, OToole PW: Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori. J Med Microbiol 2009;58:996-1005.